About Investigacion y Biomedicina de Chihuahua, S.C.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Investigacion y Biomedicina de Chihuahua, S.C.
During the past decade, Investigacion y Biomedicina de Chihuahua, S.C. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 18 clinical trials were completed, i.e. on
average, 94.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Investigacion y Biomedicina de Chihuahua, S.C." #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 7 trials
sponsored, "R-Pharm International, LLC" with 3 trials sponsored, "EMD Serono" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc."
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Investigacion y Biomedicina de Chihuahua, S.C."
#1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Investigacion y Biomedicina de Chihuahua, S.C.
According to Clinical.Site data, the most researched conditions in "Investigacion y Biomedicina de Chihuahua, S.C." are
"Rheumatoid Arthritis" (9 trials), "Arthritis, Rheumatoid" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Investigacion y Biomedicina de Chihuahua, S.C." in a lesser frequency.
Clinical Trials Intervention Types at Investigacion y Biomedicina de Chihuahua, S.C.
Most popular intervention types in "Investigacion y Biomedicina de Chihuahua, S.C." are "Drug" (22 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (3 trials), "Adalimumab" (2 trials), "Atacicept 150 mg" (2 trials) and "Ixekizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Investigacion y Biomedicina de Chihuahua, S.C.
The vast majority of trials in "Investigacion y Biomedicina de Chihuahua, S.C." are
23 trials for "All" genders.
Clinical Trials Status at Investigacion y Biomedicina de Chihuahua, S.C.
Currently, there are NaN active trials in "Investigacion y Biomedicina de Chihuahua, S.C.".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Investigacion y Biomedicina de Chihuahua, S.C.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Investigacion y Biomedicina de Chihuahua, S.C., 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".